Breaking News Instant updates and real-time market news.

OZK

Bank OZK

$37.80 /

-0.595 (-1.55%)

06:36
07/07/22
07/07
06:36
07/07/22
06:36

Bank OZK downgraded to Market Perform from Outperform at Raymond James

Raymond James analyst Michael Rose downgraded Bank OZK to Market Perform from Outperform.

  • 22

    Jul

OTHER BREAKING NEWS FROM THE FLY

Earnings
RumbleON reaffirms FY22 revenue view $1.9B-$2.0B, consensus $1.93B » 07:20
08/09/22
08/09
07:20
08/09/22
07:20
RMBL

RumbleON

$20.39 /

+1.26 (+6.59%)

Reaffirms FY22 Adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RMBL RumbleON
$20.39 /

+1.26 (+6.59%)

RMBL RumbleON
$20.39 /

+1.26 (+6.59%)

07/12/22 B. Riley
RumbleON price target lowered to $38 from $41 at B. Riley
07/12/22 Baird
RumbleON price target lowered to $25 from $30 at Baird
06/21/22 B. Riley
RumbleON price target lowered to $41 from $53 at B. Riley
05/11/22 B. Riley
RumbleON price target lowered to $53 from $70 at B. Riley
RMBL RumbleON
$20.39 /

+1.26 (+6.59%)

  • 26
    Aug
RMBL RumbleON
$20.39 /

+1.26 (+6.59%)

Recommendations
Crispr Therapeutics price target raised to $90 from $74 at Credit Suisse » 07:20
08/09/22
08/09
07:20
08/09/22
07:20
CRSP

Crispr Therapeutics

$81.33 /

-0.02 (-0.02%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

05:33 Today Barclays
Crispr Therapeutics downgraded to Equal Weight from Overweight at Barclays
08/08/22 Chardan
Crispr Therapeutics price target lowered to $154 from $164 at Chardan
08/02/22 Citi
Crispr Therapeutics price target raised to $83 from $53 at Citi
06/23/22 Oppenheimer
Crispr Therapeutics price target lowered to $122 from $150 at Oppenheimer
CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

CRSP Crispr Therapeutics
$81.33 /

-0.02 (-0.02%)

Hot Stocks
Kymera Therapeutics expects cash to fund operations into 2025 » 07:20
08/09/22
08/09
07:20
08/09/22
07:20
KYMR

Kymera Therapeutics

$31.44 /

+0.35 (+1.13%)

As of June 30, 2022,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KYMR Kymera Therapeutics
$31.44 /

+0.35 (+1.13%)

KYMR Kymera Therapeutics
$31.44 /

+0.35 (+1.13%)

08/03/22 Goldman Sachs
Kymera Therapeutics initiated with a Buy at Goldman Sachs
07/20/22 SVB Securities
Kymera Therapeutics initiated with a Market Perform at SVB Securities
06/01/22 Wells Fargo
Kymera Therapeutics price target lowered to $35 from $62 at Wells Fargo
05/23/22 Piper Sandler
Kymera Therapeutics price target lowered to $43 from $91 at Piper Sandler
KYMR Kymera Therapeutics
$31.44 /

+0.35 (+1.13%)

KYMR Kymera Therapeutics
$31.44 /

+0.35 (+1.13%)

Hot Stocks
Dine Brands sees FY22 capital expenditures $33M-$38M » 07:20
08/09/22
08/09
07:20
08/09/22
07:20
DIN

Dine Brands

$72.34 /

+1.72 (+2.44%)

Sees FY22 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIN Dine Brands
$72.34 /

+1.72 (+2.44%)

DIN Dine Brands
$72.34 /

+1.72 (+2.44%)

07/19/22 Raymond James
Dine Brands price target lowered to $85 from $95 at Raymond James
07/08/22 Wedbush
Wedbush sees Dine Brands, Wingsstop, Wendy's as Best Ideas in restaurants
06/09/22 Barclays
Dine Brands price target lowered to $88 from $93 at Barclays
03/10/22 Truist
Dine Brands price target raised to $114 from $112 at Truist
DIN Dine Brands
$72.34 /

+1.72 (+2.44%)

Earnings
Chicago Atlantic expects 2H adjusted distributable earnings $1.00-$1.05 » 07:20
08/09/22
08/09
07:20
08/09/22
07:20
REFI

Chicago Atlantic

$15.54 /

+0.17 (+1.11%)

Adjusted Distributable…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REFI Chicago Atlantic
$15.54 /

+0.17 (+1.11%)

REFI Chicago Atlantic
$15.54 /

+0.17 (+1.11%)

04/18/22 EF Hutton
Chicago Atlantic initiated with a Buy at EF Hutton
03/23/22 Oppenheimer
Chicago Atlantic price target raised to $18 from $1 at Oppenheimer
03/23/22 Oppenheimer
Chicago Atlantic price target raised to $18 from $1 at Oppenheimer
01/03/22 Lake Street
Chicago Atlantic initiated with a Buy at Lake Street
REFI Chicago Atlantic
$15.54 /

+0.17 (+1.11%)

  • 08
    Dec
REFI Chicago Atlantic
$15.54 /

+0.17 (+1.11%)

Recommendations
Freshpet price target lowered to $75 from $135 at Stifel » 07:19
08/09/22
08/09
07:19
08/09/22
07:19
FRPT

Freshpet

$56.39 /

+1.895 (+3.48%)

Stifel analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

07:18 Today Truist
Freshpet price target lowered to $70 from $130 at Truist
06:41 Today Baird
Freshpet price target lowered to $90 from $100 at Baird
05/20/22 Atlantic Equities
Atlantic Equities sees more volatility for Freshpet, downgrades shares
05/20/22 Atlantic Equities
Freshpet downgraded to Neutral from Overweight at Atlantic Equities
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

  • 04
    May
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

Earnings
Kymera Therapeutics reports Q2 EPS (78c), consensus (72c) » 07:19
08/09/22
08/09
07:19
08/09/22
07:19
KYMR

Kymera Therapeutics

$31.44 /

+0.35 (+1.13%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KYMR Kymera Therapeutics
$31.44 /

+0.35 (+1.13%)

KYMR Kymera Therapeutics
$31.44 /

+0.35 (+1.13%)

08/03/22 Goldman Sachs
Kymera Therapeutics initiated with a Buy at Goldman Sachs
07/20/22 SVB Securities
Kymera Therapeutics initiated with a Market Perform at SVB Securities
06/01/22 Wells Fargo
Kymera Therapeutics price target lowered to $35 from $62 at Wells Fargo
05/23/22 Piper Sandler
Kymera Therapeutics price target lowered to $43 from $91 at Piper Sandler
KYMR Kymera Therapeutics
$31.44 /

+0.35 (+1.13%)

KYMR Kymera Therapeutics
$31.44 /

+0.35 (+1.13%)

Earnings
Ionis Pharmaceuticals reports Q2 EPS (74c), consensus (62c) » 07:19
08/09/22
08/09
07:19
08/09/22
07:19
IONS

Ionis Pharmaceuticals

$45.71 /

+0.02 (+0.04%)

Reports Q2 revenue $134M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$45.71 /

+0.02 (+0.04%)

IONS Ionis Pharmaceuticals
$45.71 /

+0.02 (+0.04%)

07/26/22 Piper Sandler
Ionis Pharmaceuticals price target raised to $58 from $55 at Piper Sandler
07/20/22 Piper Sandler
Piper adjusts Ionis' Spinraza royalties estimate following Biogen report
07/18/22 Oppenheimer
Ionis Pharmaceuticals assumed with an Outperform at Oppenheimer
06/23/22 Citi
Citi adds AutoZone, Thermo Fisher, Ionis to 'Focus List'
IONS Ionis Pharmaceuticals
$45.71 /

+0.02 (+0.04%)

IONS Ionis Pharmaceuticals
$45.71 /

+0.02 (+0.04%)

Earnings
Chicago Atlantic reports Q2 EPS 42c vs. 44c last year » 07:19
08/09/22
08/09
07:19
08/09/22
07:19
REFI

Chicago Atlantic

$15.54 /

+0.17 (+1.11%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
REFI Chicago Atlantic
$15.54 /

+0.17 (+1.11%)

REFI Chicago Atlantic
$15.54 /

+0.17 (+1.11%)

04/18/22 EF Hutton
Chicago Atlantic initiated with a Buy at EF Hutton
03/23/22 Oppenheimer
Chicago Atlantic price target raised to $18 from $1 at Oppenheimer
03/23/22 Oppenheimer
Chicago Atlantic price target raised to $18 from $1 at Oppenheimer
01/03/22 Lake Street
Chicago Atlantic initiated with a Buy at Lake Street
REFI Chicago Atlantic
$15.54 /

+0.17 (+1.11%)

  • 08
    Dec
REFI Chicago Atlantic
$15.54 /

+0.17 (+1.11%)

Recommendations
ALX Oncology price target lowered to $38 from $43 at Credit Suisse » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
ALXO

ALX Oncology

$11.76 /

+0.265 (+2.31%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALXO ALX Oncology
$11.76 /

+0.265 (+2.31%)

ALXO ALX Oncology
$11.76 /

+0.265 (+2.31%)

06/06/22 Stifel
ALX Oncology price target lowered to $16 from $35 at Stifel
06/03/22 Piper Sandler
ALX's evorpacept best-in-class aong CD47-targeting agents, says Piper Sandler
05/18/22 Piper Sandler
ALX Oncology price target lowered to $48 from $70 at Piper Sandler
03/14/22 Cantor Fitzgerald
ALX Oncology price target lowered to $60 from $103 at Cantor Fitzgerald
ALXO ALX Oncology
$11.76 /

+0.265 (+2.31%)

Earnings
Kaltura cuts FY22 revenue $168.4M-$171.6M from $173.3M-$178.2M » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
KLTR

Kaltura

$2.66 /

-0.04 (-1.48%)

FY22 revenue consensus…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

02/24/22 Canaccord
Kaltura price target lowered to $4.00 from $10 at Canaccord
02/24/22 Deutsche Bank
Kaltura price target lowered to $2.50 from $5.50 at Deutsche Bank
02/23/22 BofA
Kaltura downgraded to Neutral from Buy at BofA
02/23/22 BofA
Kaltura downgraded to Neutral from Buy at BofA
KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

Earnings
Kaltura sees Q3 revenue $40.8M-$41.7M, consensus $44.41M » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
KLTR

Kaltura

$2.66 /

-0.04 (-1.48%)

Sees Q3 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

02/24/22 Canaccord
Kaltura price target lowered to $4.00 from $10 at Canaccord
02/24/22 Deutsche Bank
Kaltura price target lowered to $2.50 from $5.50 at Deutsche Bank
02/23/22 BofA
Kaltura downgraded to Neutral from Buy at BofA
02/23/22 BofA
Kaltura downgraded to Neutral from Buy at BofA
KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

Recommendations
JPMorgan says 'now is the time to buy' SVB Financial » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
SIVB

SVB Financial

$412.82 /

-1.75 (-0.42%)

JPMorgan analyst Steven…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIVB SVB Financial
$412.82 /

-1.75 (-0.42%)

SIVB SVB Financial
$412.82 /

-1.75 (-0.42%)

07/25/22 Maxim
SVB Financial price target lowered to $900 from $1,100 at Maxim
07/25/22 Truist
SVB Financial price target lowered to $500 from $557 at Truist
07/25/22 Barclays
SVB Financial price target lowered to $638 from $789 at Barclays
07/25/22 Evercore ISI
SVB Financial upgraded to Outperform from In Line at Evercore ISI
SIVB SVB Financial
$412.82 /

-1.75 (-0.42%)

  • 10
    Aug
SIVB SVB Financial
$412.82 /

-1.75 (-0.42%)

SIVB SVB Financial
$412.82 /

-1.75 (-0.42%)

Recommendations
Freshpet price target lowered to $70 from $130 at Truist » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
FRPT

Freshpet

$56.39 /

+1.895 (+3.48%)

Truist analyst Bill…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

06:41 Today Baird
Freshpet price target lowered to $90 from $100 at Baird
05/20/22 Atlantic Equities
Atlantic Equities sees more volatility for Freshpet, downgrades shares
05/20/22 Atlantic Equities
Freshpet downgraded to Neutral from Overweight at Atlantic Equities
05/03/22 Cowen
Freshpet price target lowered to $163 from $181 at Cowen
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

  • 04
    May
FRPT Freshpet
$56.39 /

+1.895 (+3.48%)

Earnings
Dine Brands reports Q2 adjusted EPS $1.65, consensus $1.63 » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
DIN

Dine Brands

$72.34 /

+1.72 (+2.44%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DIN Dine Brands
$72.34 /

+1.72 (+2.44%)

DIN Dine Brands
$72.34 /

+1.72 (+2.44%)

07/19/22 Raymond James
Dine Brands price target lowered to $85 from $95 at Raymond James
07/08/22 Wedbush
Wedbush sees Dine Brands, Wingsstop, Wendy's as Best Ideas in restaurants
06/09/22 Barclays
Dine Brands price target lowered to $88 from $93 at Barclays
03/10/22 Truist
Dine Brands price target raised to $114 from $112 at Truist
DIN Dine Brands
$72.34 /

+1.72 (+2.44%)

Hot Stocks
TransDigm says 2022 guidance 'remains suspended' » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
TDG

TransDigm

$642.21 /

+4.01 (+0.63%)

Cites continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDG TransDigm
$642.21 /

+4.01 (+0.63%)

TDG TransDigm
$642.21 /

+4.01 (+0.63%)

07/19/22 Truist
TransDigm price target lowered to $700 from $786 at Truist
07/18/22 Cowen
Cowen believes Aerospace and Defense quarterly results to be mixed
05/11/22 Susquehanna
TransDigm price target lowered to $620 from $720 at Susquehanna
05/11/22 Wells Fargo
TransDigm price target lowered to $620 from $700 at Wells Fargo
TDG TransDigm
$642.21 /

+4.01 (+0.63%)

TDG TransDigm
$642.21 /

+4.01 (+0.63%)

Hot Stocks
908 Devices buys TRACE Analytics for $15.3M up front, up to $2M contingent » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
MASS

908 Devices

$21.30 /

-3.73 (-14.90%)

908 Devices announces…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MASS 908 Devices
$21.30 /

-3.73 (-14.90%)

MASS 908 Devices
$21.30 /

-3.73 (-14.90%)

10/14/21 Cowen
908 Devices coverage transferred at Cowen
MASS 908 Devices
$21.30 /

-3.73 (-14.90%)

  • 11
    Nov
MASS 908 Devices
$21.30 /

-3.73 (-14.90%)

Earnings
Sterling Check raises 2022 revenue view $785M-$795M from $770M-$780M » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
STER

Sterling Check

$19.88 /

+0.55 (+2.85%)

Consensus $775.33M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STER Sterling Check
$19.88 /

+0.55 (+2.85%)

05/16/22 Barclays
Sterling Check price target lowered to $18 from $22 at Barclays
04/11/22 Morgan Stanley
Sterling Check downgraded to Equal Weight from Overweight at Morgan Stanley
03/16/22 Barclays
Sterling Check price target lowered to $22 from $28 at Barclays
03/03/22 Baird
Sterling Check price target lowered to $31 from $34 at Baird
STER Sterling Check
$19.88 /

+0.55 (+2.85%)

  • 23
    Sep
Earnings
RumbleON reports Q2 adjusted EPS $1.20, consensus 97c » 07:18
08/09/22
08/09
07:18
08/09/22
07:18
RMBL

RumbleON

$20.39 /

+1.26 (+6.59%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RMBL RumbleON
$20.39 /

+1.26 (+6.59%)

RMBL RumbleON
$20.39 /

+1.26 (+6.59%)

07/12/22 B. Riley
RumbleON price target lowered to $38 from $41 at B. Riley
07/12/22 Baird
RumbleON price target lowered to $25 from $30 at Baird
06/21/22 B. Riley
RumbleON price target lowered to $41 from $53 at B. Riley
05/11/22 B. Riley
RumbleON price target lowered to $53 from $70 at B. Riley
RMBL RumbleON
$20.39 /

+1.26 (+6.59%)

  • 26
    Aug
RMBL RumbleON
$20.39 /

+1.26 (+6.59%)

Hot Stocks
TransDigm declares special cash dividend of $18.50 per share » 07:17
08/09/22
08/09
07:17
08/09/22
07:17
TDG

TransDigm

$642.21 /

+4.01 (+0.63%)

The company announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDG TransDigm
$642.21 /

+4.01 (+0.63%)

TDG TransDigm
$642.21 /

+4.01 (+0.63%)

07/19/22 Truist
TransDigm price target lowered to $700 from $786 at Truist
07/18/22 Cowen
Cowen believes Aerospace and Defense quarterly results to be mixed
05/11/22 Susquehanna
TransDigm price target lowered to $620 from $720 at Susquehanna
05/11/22 Wells Fargo
TransDigm price target lowered to $620 from $700 at Wells Fargo
TDG TransDigm
$642.21 /

+4.01 (+0.63%)

TDG TransDigm
$642.21 /

+4.01 (+0.63%)

Recommendations
CarGurus price target lowered to $38 from $44 at Truist » 07:16
08/09/22
08/09
07:16
08/09/22
07:16
CARG

CarGurus

$25.77 /

+0.01 (+0.04%)

Truist analyst Naved Khan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CARG CarGurus
$25.77 /

+0.01 (+0.04%)

CARG CarGurus
$25.77 /

+0.01 (+0.04%)

07/25/22 Truist
CarGurus price target lowered to $44 from $53 at Truist
06/30/22 JMP Securities
CarGurus resumed with a Market Perform at JMP Securities
06/21/22 BTIG
CarGurus price target lowered to $33 from $40 at BTIG
05/10/22 RBC Capital
CarGurus price target lowered to $45 from $56 at RBC Capital
CARG CarGurus
$25.77 /

+0.01 (+0.04%)

CARG CarGurus
$25.77 /

+0.01 (+0.04%)

Earnings
TransDigm reports Q3 adjusted EPS $4.85, consensus $4.46 » 07:16
08/09/22
08/09
07:16
08/09/22
07:16
TDG

TransDigm

$642.21 /

+4.01 (+0.63%)

Reports Q3 revenue $1.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDG TransDigm
$642.21 /

+4.01 (+0.63%)

TDG TransDigm
$642.21 /

+4.01 (+0.63%)

07/19/22 Truist
TransDigm price target lowered to $700 from $786 at Truist
07/18/22 Cowen
Cowen believes Aerospace and Defense quarterly results to be mixed
05/11/22 Susquehanna
TransDigm price target lowered to $620 from $720 at Susquehanna
05/11/22 Wells Fargo
TransDigm price target lowered to $620 from $700 at Wells Fargo
TDG TransDigm
$642.21 /

+4.01 (+0.63%)

TDG TransDigm
$642.21 /

+4.01 (+0.63%)

Earnings
Sterling Check reports Q2 adjusted EPS 33c, consensus 25c » 07:16
08/09/22
08/09
07:16
08/09/22
07:16
STER

Sterling Check

$19.88 /

+0.55 (+2.85%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STER Sterling Check
$19.88 /

+0.55 (+2.85%)

05/16/22 Barclays
Sterling Check price target lowered to $18 from $22 at Barclays
04/11/22 Morgan Stanley
Sterling Check downgraded to Equal Weight from Overweight at Morgan Stanley
03/16/22 Barclays
Sterling Check price target lowered to $22 from $28 at Barclays
03/03/22 Baird
Sterling Check price target lowered to $31 from $34 at Baird
STER Sterling Check
$19.88 /

+0.55 (+2.85%)

  • 23
    Sep
Recommendations
ShockWave Medical price target raised to $255 from $201 at Morgan Stanley » 07:16
08/09/22
08/09
07:16
08/09/22
07:16
SWAV

ShockWave Medical

$221.92 /

-0.94 (-0.42%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

06:52 Today Wells Fargo
ShockWave Medical price target raised to $255 from $176 at Wells Fargo
04:53 Today Piper Sandler
ShockWave Medical price target raised to $278 from $245 at Piper Sandler
05/23/22 Piper Sandler
ShockWave Medical's China approval adds growth driver, says Piper Sandler
05/10/22 Canaccord
ShockWave Medical price target lowered to $190 from $221 at Canaccord
SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

Earnings
Kaltura reports Q2 adjusted EPS (8c), consensus (10c) » 07:16
08/09/22
08/09
07:16
08/09/22
07:16
KLTR

Kaltura

$2.66 /

-0.04 (-1.48%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

02/24/22 Canaccord
Kaltura price target lowered to $4.00 from $10 at Canaccord
02/24/22 Deutsche Bank
Kaltura price target lowered to $2.50 from $5.50 at Deutsche Bank
02/23/22 BofA
Kaltura downgraded to Neutral from Buy at BofA
02/23/22 BofA
Kaltura downgraded to Neutral from Buy at BofA
KLTR Kaltura
$2.66 /

-0.04 (-1.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.